{"pmid":32422693,"title":"Teledermatology for COVID-19 cutaneous lesions: substitute or supplement?","text":["Teledermatology for COVID-19 cutaneous lesions: substitute or supplement?","In the context of COVID-19 pandemic, teledermatology is being favored over in-person consultation in order to avoid the possibility of virus transmission(1) . In France, COVID-19 wasn't known to cause cutaneous manifestations before April 6(th) 2020, when an alert about possible associated skin symptoms was raised to the general public and the professional social network(2-4) . We aimed to assess the impact of alerting about COVID-associated lesions on the activity of urgent teledermatology (TD) and the activity of dermatologic emergencies unit (DEU) of two university hospitals during this pandemic.","J Eur Acad Dermatol Venereol","Skayem, C","Cassius, C","Ben Kahla, M","Fiani, C","Frumholtz, L","Mrad, M","Petit, A","Zuelgaray, E","Bagot, M","Bouaziz, J D","Duong, T A","32422693"],"abstract":["In the context of COVID-19 pandemic, teledermatology is being favored over in-person consultation in order to avoid the possibility of virus transmission(1) . In France, COVID-19 wasn't known to cause cutaneous manifestations before April 6(th) 2020, when an alert about possible associated skin symptoms was raised to the general public and the professional social network(2-4) . We aimed to assess the impact of alerting about COVID-associated lesions on the activity of urgent teledermatology (TD) and the activity of dermatologic emergencies unit (DEU) of two university hospitals during this pandemic."],"journal":"J Eur Acad Dermatol Venereol","authors":["Skayem, C","Cassius, C","Ben Kahla, M","Fiani, C","Frumholtz, L","Mrad, M","Petit, A","Zuelgaray, E","Bagot, M","Bouaziz, J D","Duong, T A"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32422693","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1111/jdv.16630","keywords":["covid-19","cutaneous lesions","dermatological emergencies","emergency unit","teledermatology"],"locations":["France"],"countries":["France"],"countries_codes":["FRA|France"],"topics":["Prevention"],"weight":1,"_version_":1667254896761503747,"score":9.490897,"similar":[{"pmid":32458588,"title":"Teledermatologic monitoring for chronic cutaneous autoimmune diseases with smartworking during Covid-19 emergency in a tertiary center in Italy.","text":["Teledermatologic monitoring for chronic cutaneous autoimmune diseases with smartworking during Covid-19 emergency in a tertiary center in Italy.","Because of the COVID-19 emergency, on March 9, 2020 Italy went in lock-down imposing the closure of non-urgent outpatient clinics devoted to care of chronic, severe, inflammatory skin diseases that require periodic follow-up. In this emergency situation, due to the lack of a teledermatology platform and in order not to leave our vulnerable high-need patients without proper follow-up, we started a teledermatologic service in smartworking using phone calls and emails. The total number of patients scheduled was 195; in 12 cases we were not able to talk to the patients. Remote monitoring was performed in 183 patients (126 moderate to severe psoriasis, 10 severe acne, 11 severe atopic dermatitis, 11 hidradenitis suppurativa, 9 blistering autoimmune diseases, 16 other autoimmune skin diseases). During remote-visits several interventions were conducted: triage for COVID-19 suspected symptoms, email check of clinical pictures and of laboratory examinations, advices for topical and systemic therapy continuation or discontinuation/switch and re-schedule of next appointment. Only 5 patients required personal office visit (2.6%), reducing consistently the number of face-to face visits. Our real-life experience shows that remote monitoring was effective in preventing unnecessary worsening of severe chronic skin diseases and poor outcomes due to withdrawal of current therapy. This article is protected by copyright. All rights reserved.","Dermatol Ther","Brunasso, Alexandra Maria Giovanna","Massone, Cesare","32458588"],"abstract":["Because of the COVID-19 emergency, on March 9, 2020 Italy went in lock-down imposing the closure of non-urgent outpatient clinics devoted to care of chronic, severe, inflammatory skin diseases that require periodic follow-up. In this emergency situation, due to the lack of a teledermatology platform and in order not to leave our vulnerable high-need patients without proper follow-up, we started a teledermatologic service in smartworking using phone calls and emails. The total number of patients scheduled was 195; in 12 cases we were not able to talk to the patients. Remote monitoring was performed in 183 patients (126 moderate to severe psoriasis, 10 severe acne, 11 severe atopic dermatitis, 11 hidradenitis suppurativa, 9 blistering autoimmune diseases, 16 other autoimmune skin diseases). During remote-visits several interventions were conducted: triage for COVID-19 suspected symptoms, email check of clinical pictures and of laboratory examinations, advices for topical and systemic therapy continuation or discontinuation/switch and re-schedule of next appointment. Only 5 patients required personal office visit (2.6%), reducing consistently the number of face-to face visits. Our real-life experience shows that remote monitoring was effective in preventing unnecessary worsening of severe chronic skin diseases and poor outcomes due to withdrawal of current therapy. This article is protected by copyright. All rights reserved."],"journal":"Dermatol Ther","authors":["Brunasso, Alexandra Maria Giovanna","Massone, Cesare"],"date":"2020-05-28T11:00:00Z","year":2020,"_id":"32458588","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1111/dth.13695","keywords":["covid-19","teledermatology","atopic dermatitis","psoriasis","smartworking","telemonitoring"],"locations":["Italy","Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1667967699031949312,"score":222.93257},{"pmid":32441373,"title":"Will Teledermatology be the silver lining during and after COVID-19?","text":["Will Teledermatology be the silver lining during and after COVID-19?","The novel coronavirus disease (COVID-19) has limited traditional consultation and minimized healthcare access. Teledermatology has come to the rescue in this situation by extending consultation for non-essential conditions to the comfort of patient's homes. This limits the risk of exposure of both doctors and patients to SARS-Cov-2. And while there is a reported increase in teleconsultations during the ongoing pandemic, there are some demerits that avert the shift to virtualized healthcare. The authors conducted an online survey to further understand the hesitancy, limitations, merits and the demographic of dermatologists who were conducive to teledermatology and this data was analysed and presented in this article. While teledermatology might never replace physical consultation, it definitely serves an adjunctive role in the post-COVID-era, provided adequate regulatory measures are in place. This article is protected by copyright. All rights reserved.","Dermatol Ther","Sharma, Aseem","Jindal, Veenu","Singla, Palvi","Goldust, Mohamad","Mhatre, Madhulika","32441373"],"abstract":["The novel coronavirus disease (COVID-19) has limited traditional consultation and minimized healthcare access. Teledermatology has come to the rescue in this situation by extending consultation for non-essential conditions to the comfort of patient's homes. This limits the risk of exposure of both doctors and patients to SARS-Cov-2. And while there is a reported increase in teleconsultations during the ongoing pandemic, there are some demerits that avert the shift to virtualized healthcare. The authors conducted an online survey to further understand the hesitancy, limitations, merits and the demographic of dermatologists who were conducive to teledermatology and this data was analysed and presented in this article. While teledermatology might never replace physical consultation, it definitely serves an adjunctive role in the post-COVID-era, provided adequate regulatory measures are in place. This article is protected by copyright. All rights reserved."],"journal":"Dermatol Ther","authors":["Sharma, Aseem","Jindal, Veenu","Singla, Palvi","Goldust, Mohamad","Mhatre, Madhulika"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32441373","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1111/dth.13643","keywords":["artifical intelligence","covid-19","sars-cov-2","teledermatology","survey","teledermatopathology","teledermoscopy"],"topics":["Prevention"],"weight":1,"_version_":1667535119508832256,"score":219.48329},{"pmid":32320091,"title":"Dermatologists and SARS-CoV-2: The impact of the pandemic on daily practice.","text":["Dermatologists and SARS-CoV-2: The impact of the pandemic on daily practice.","Since the first case of \"pneumonia of unknown aetiology\" was diagnosed at the Wuhan Jinyintan Hospital in China on 30 December 2019, what was recognised thereafter as \"severe acute respiratory syndrome coronavirus 2\" (SARS-CoV-2) has spread over the four continents, causing the respiratory manifestations of Coronavirus disease-19 (COVID- 19) and satisfying the epidemiological criteria for a label of \"pandemic.\" The ongoing SARS-CoV-2 pandemic is having a huge impact on dermatological practice including the marked reduction of face-to-face consultations in favour of teledermatology, the uncertainties concerning the outcome of COVID-19 infection in patients with common inflammatory disorders such as psoriasis or atopic dermatitis receiving immunosuppressive/immunomodulating systemic therapies; the direct involvement of dermatologists in COVID-19 care for patients assistance and new research needs to be addressed. It is not known yet, if skin lesions and derangement of the skin barrier could make it easier for SARS-CoV-2 to transmit via indirect contact; it remains to be defined if specific mucosal or skin lesions are associated with SARS-CoV-2 infection, although some unpublished observations indicate the occurrence of a transient varicelliform exanthema during the early phase of the infection. SARS-CoV-2 is a new pathogen for humans that is highly contagious, can spread quickly, and is capable of causing enormous health, economic and societal impacts in any setting. The consequences may continue long after the pandemic resolves, and new management modalities for dermatology may originate from the COVID-19 disaster. Learning from experience may help to cope with future major societal changes.","J Eur Acad Dermatol Venereol","Gisondi, P","Piaserico, S","Conti, A","Naldi, L","32320091"],"abstract":["Since the first case of \"pneumonia of unknown aetiology\" was diagnosed at the Wuhan Jinyintan Hospital in China on 30 December 2019, what was recognised thereafter as \"severe acute respiratory syndrome coronavirus 2\" (SARS-CoV-2) has spread over the four continents, causing the respiratory manifestations of Coronavirus disease-19 (COVID- 19) and satisfying the epidemiological criteria for a label of \"pandemic.\" The ongoing SARS-CoV-2 pandemic is having a huge impact on dermatological practice including the marked reduction of face-to-face consultations in favour of teledermatology, the uncertainties concerning the outcome of COVID-19 infection in patients with common inflammatory disorders such as psoriasis or atopic dermatitis receiving immunosuppressive/immunomodulating systemic therapies; the direct involvement of dermatologists in COVID-19 care for patients assistance and new research needs to be addressed. It is not known yet, if skin lesions and derangement of the skin barrier could make it easier for SARS-CoV-2 to transmit via indirect contact; it remains to be defined if specific mucosal or skin lesions are associated with SARS-CoV-2 infection, although some unpublished observations indicate the occurrence of a transient varicelliform exanthema during the early phase of the infection. SARS-CoV-2 is a new pathogen for humans that is highly contagious, can spread quickly, and is capable of causing enormous health, economic and societal impacts in any setting. The consequences may continue long after the pandemic resolves, and new management modalities for dermatology may originate from the COVID-19 disaster. Learning from experience may help to cope with future major societal changes."],"journal":"J Eur Acad Dermatol Venereol","authors":["Gisondi, P","Piaserico, S","Conti, A","Naldi, L"],"date":"2020-04-23T11:00:00Z","year":2020,"_id":"32320091","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1111/jdv.16515","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666138493606166529,"score":160.40448},{"pmid":32330324,"title":"Acral cutaneous lesions in the Time of COVID-19.","text":["Acral cutaneous lesions in the Time of COVID-19.","Coronavirus disease 2019 (COVID-19) has become a pandemic condition, yet little is known about its dermatologic manifestations. We report here on peculiar (perniosis-like) skin lesions, unreported in the previous years, observed in young outpatients visited in our Dermatologic Unit in the last 4 weeks of COVID-19 pandemic (March-April 2020). Similar cases were referred to us in the same period by Pediatricians and Dermatologists from Italy and European countries.","J Eur Acad Dermatol Venereol","Recalcati, S","Barbagallo, T","Frasin, L A","Prestinari, F","Cogliardi, A","Provero, M C","Dainese, E","Vanzati, A","Fantini, F","32330324"],"abstract":["Coronavirus disease 2019 (COVID-19) has become a pandemic condition, yet little is known about its dermatologic manifestations. We report here on peculiar (perniosis-like) skin lesions, unreported in the previous years, observed in young outpatients visited in our Dermatologic Unit in the last 4 weeks of COVID-19 pandemic (March-April 2020). Similar cases were referred to us in the same period by Pediatricians and Dermatologists from Italy and European countries."],"journal":"J Eur Acad Dermatol Venereol","authors":["Recalcati, S","Barbagallo, T","Frasin, L A","Prestinari, F","Cogliardi, A","Provero, M C","Dainese, E","Vanzati, A","Fantini, F"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330324","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1111/jdv.16533","keywords":["covid-19","acral lesions","children","cutaneous manifestations","pediatric population","skin"],"locations":["Pediatricians","Dermatologists","Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Diagnosis"],"weight":1,"_version_":1666138494572953600,"score":157.42816},{"pmid":32369632,"title":"Chilblain-like lesions: a case series of 41 patients during the COVID-19 pandemic.","text":["Chilblain-like lesions: a case series of 41 patients during the COVID-19 pandemic.","During the COVID-19 pandemic dermatologists in countries with the highest incidence have noted an increase in consultations for chilblain-like lesions. In the Region of Murcia, a south-east Spanish area with around 1.5 million population, dermatologists have collected these findings during one week. In most cases photographs were taken by the patients themselves and referred to their General Practitioners before getting to us via our regional teledermatology platform. Patients were asked about fever, cough, shortness of breath or gastrointestinal symptoms.","Clin Exp Dermatol","Lopez-Robles, J","de la Hera, I","Pardo, J","Martinez, J","Cutillas-Marco, E","32369632"],"abstract":["During the COVID-19 pandemic dermatologists in countries with the highest incidence have noted an increase in consultations for chilblain-like lesions. In the Region of Murcia, a south-east Spanish area with around 1.5 million population, dermatologists have collected these findings during one week. In most cases photographs were taken by the patients themselves and referred to their General Practitioners before getting to us via our regional teledermatology platform. Patients were asked about fever, cough, shortness of breath or gastrointestinal symptoms."],"journal":"Clin Exp Dermatol","authors":["Lopez-Robles, J","de la Hera, I","Pardo, J","Martinez, J","Cutillas-Marco, E"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32369632","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1111/ced.14275","locations":["Region of Murcia","Spanish"],"countries":["Spain"],"countries_codes":["ESP|Spain"],"topics":["Prevention"],"weight":1,"_version_":1666138496256966658,"score":155.87915}]}